{"raw_mentions": "Antibodies of the present invention preferably dissociate from CLDN6 with a dissociation equilibrium constant (KD) of approximately 1-100 nM or less.\nIn preferred embodiments, antibodies of the present invention can be characterized by one or more of the following properties: b) a binding affinity to CLDN6 of about 100 nM or less, preferably, about 5-10 nM or less and, more preferably, about 1-3 nM or less,"}
{"final_json": [{"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "KD", "value": "1-100", "unit": "nM"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "binding affinity", "value": "100", "unit": "nM"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "binding affinity", "value": "5-10", "unit": "nM"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "binding affinity", "value": "1-3", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAntibodies of the present invention preferably have EC50 values for binding to CLDN6 of 6500 ng/ml or lower, 3000 ng/ml or lower, 2500 ng/ml or lower, 2000 ng/ml or lower, 1500 ng/ml or lower, 1000 ng/ml or lower, 500 ng/ml or lower, 400 ng/ml or lower, 300 ng/ml or lower, 200 ng/ml or lower, or 100 ng/ml or lower.\nPreferably, the term \"significant affinity\" refers to the binding to a predetermined target with a dissociation constant (K<sub>D</sub>) of 10<sup>-5</sup> M or lower, 10<sup>-6</sup> M or lower, 10<sup>-7</sup> M or lower, 10<sup>-8</sup> M or lower, 10<sup>-9</sup> M or lower, 10<sup>-10</sup> M or lower, 10<sup>-11</sup> M or lower, or 10<sup>-12</sup> M or lower."}
{"final_json": [{"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "6500", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "3000", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "2500", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "2000", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "1500", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "1000", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "500", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "400", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "300", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "200", "unit": "ng/ml"}, {"molecule_name": "Antibodies of the present invention", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "100", "unit": "ng/ml"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-5", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-6", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-7", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-8", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-9", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-10", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-11", "unit": "M"}, {"molecule_name": null, "protein_target_name": "a predetermined target", "binding_metric": "Kd", "value": "10^-12", "unit": "M"}]}
{"raw_mentions": "MuMAB 59A, 60A, 61D, 64A, 65A, 66B and 67A exhibited very low EC50 values (EC50 200-500 ng/ml) and saturation of binding was achieved at low concentrations (Fig. 7)."}
{"final_json": [{"molecule_name": "MuMAB 59A", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 60A", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 61D", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 64A", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 65A", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 66B", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}, {"molecule_name": "MuMAB 67A", "protein_target_name": null, "binding_metric": "EC50", "value": "200-500", "unit": "ng/ml"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nRegarding binding to human CLDN6 stably expressed on the surface of HEK293 cells, anti-CLDN6 chimeric monoclonal antibodies chimAB 64A and 89A exhibit very low EC50 values (EC50 450-600 ng/ml) and saturation of binding was achieved at low concentrations.\nChimAB 67A and 61D showed low (EC50 1000 ng/ml) and medium (EC50 2300 ng/ml) EC50 values, respectively (Fig. 12).\nRegarding binding to CLDN6 endogenously expressed in NEC8 cells, anti-CLDN6 chimeric monoclonal antibodies chimAB 64A and 89A exhibited very low EC50 values (EC50 600-650 ng/ml) and saturation of binding was achieved at low concentrations, whereas chimAB 61D and 67A showed medium (EC50 1700 ng/ml) and high (EC50 6100 ng/ml) EC50 values, respectively (Fig. 13).\nRegarding binding to CLDN6 endogenously expressed in OV90 cells, anti-CLDN6 chimeric monoclonal antibodies chimAB 64A and 89A exhibited very low EC50 values (EC50 550-600 ng/ml) and saturation of binding was achieved at low concentrations.\nChimAB 61D and 67A showed medium EC50 values (EC50 1500 ng/ml and EC50 2300 ng/ml, respectively) (Fig. 14)."}
{"final_json": [{"molecule_name": "chimAB 64A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "450-600", "unit": "ng/ml"}, {"molecule_name": "chimAB 89A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "450-600", "unit": "ng/ml"}, {"molecule_name": "chimAB 67A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "1000", "unit": "ng/ml"}, {"molecule_name": "chimAB 61D", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "2300", "unit": "ng/ml"}, {"molecule_name": "chimAB 64A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "600-650", "unit": "ng/ml"}, {"molecule_name": "chimAB 89A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "600-650", "unit": "ng/ml"}, {"molecule_name": "chimAB 61D", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "1700", "unit": "ng/ml"}, {"molecule_name": "chimAB 67A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "6100", "unit": "ng/ml"}, {"molecule_name": "chimAB 64A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "550-600", "unit": "ng/ml"}, {"molecule_name": "chimAB 89A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "550-600", "unit": "ng/ml"}, {"molecule_name": "chimAB 61D", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "1500", "unit": "ng/ml"}, {"molecule_name": "chimAB 67A", "protein_target_name": "CLDN6", "binding_metric": "EC50", "value": "2300", "unit": "ng/ml"}]}
